Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
OpenAI launches ChatGPT Health to connect medical records, wellness apps - 2Attacks on Iran's Bushehr nuclear plant and on Iraq border crossing
- 3What happened to Eleven after the ambiguous 'Stranger Things' series finale? Millie Bobby Brown knows — but 'swore herself to secrecy'
- 4Liste des pr\u00eats qui ne n\u00e9cessitent pas de remboursement
- 55 Chiefs That Changed Our Opinion on Film
- Undeniably popular Historical centers: Where Craftsmanship and History Meet
- New ‘Cloud-9’ object could reveal the secrets of dark matter
- Inside the cockpit of RAF tanker during defensive mission against Iranian drones
- NASA is shooting for the moon. A guide to the Artemis II mission
- Pick Your #1 Kind Of Bread
- Fossils from China show complex life evolved millions of years earlier than once thought
- A Manual for the Right SUV for Seniors
- Machado ‘presented’ her Nobel Peace Prize medal to Trump
- Carry Nature Inside with These Staggering Plant Decisions
